ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $571,705,000 | +47.4% | 16,629 | +23.6% | 0.35% | +43.5% |
| Q4 2016 | $387,927,000 | +40.9% | 13,451 | +55.4% | 0.25% | +46.4% |
| Q3 2016 | $275,347,000 | -12.2% | 8,656 | -10.4% | 0.17% | -13.0% |
| Q2 2016 | $313,434,000 | +56.8% | 9,656 | +35.0% | 0.19% | +70.8% |
| Q1 2016 | $199,942,000 | +143.8% | 7,151 | +210.9% | 0.11% | +140.4% |
| Q4 2015 | $81,995,000 | +7.8% | 2,300 | 0.0% | 0.05% | -2.1% |
| Q3 2015 | $76,061,000 | -21.0% | 2,300 | 0.0% | 0.05% | -12.7% |
| Q2 2015 | $96,324,000 | +195.6% | 2,300 | +130.0% | 0.06% | +205.6% |
| Q1 2015 | $32,590,000 | +156.6% | 1,000 | +150.0% | 0.02% | +80.0% |
| Q4 2014 | $12,700,000 | -61.0% | 400 | -60.0% | 0.01% | -44.4% |
| Q1 2014 | $32,590,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |